文献速递心脏核医学

应用动态11C-乙酸正电子发射断层显像表征高风险酒精心脏毒性与酒精性心肌病的心肌氧化代谢和心肌外部效率

Characterization of myocardial oxidative metabolism and myocardial external efficiency in high-risk alcohol cardiotoxicity and alcoholic cardiomyopathy via dynamic 11C-Acetate positron emission tomography.
PubMed 文献 · J Nucl Cardiol · 2020-06-18

本研究纳入37例长期饮酒者(中度18例、重度19例)、5例酒精性心肌病患者和12例健康对照,行动态11C-乙酸PET扫描计算动力学参数并推导心肌氧耗量与心肌外部效率。重度饮酒组和酒精性心肌病组心肌氧耗量显著低于健康对照组和中度饮酒组,酒精性心肌病组心肌外部效率显著低于其余三组。作者认为动态11C-乙酸PET功能评估可能成为识别高风险酒精心脏毒性和酒精性心肌病队列的临床可行探针。

要点

  • 重度饮酒组和酒精性心肌病组心肌氧耗量显著低于健康对照和中度饮酒组。
  • 酒精性心肌病组心肌外部效率显著低于健康对照、中度饮酒和重度饮酒组。
  • 作者认为动态11C-乙酸PET功能评估可能成为识别高风险酒精心脏毒性的可行探针。

核心结论

  • 通过动态11C-乙酸PET显像进行功能评估,可能成为识别因成瘾性饮酒导致的高风险心脏毒性队列和酒精性心肌病的临床可行探针。

研究设计与样本

  • 招募37例长期饮酒者(中度饮酒18例、重度饮酒19例)、5例酒精性心肌病患者和12例健康对照,行动态11C-乙酸PET扫描。
  • 基于单指数模型和单组织室模型计算动力学参数(如Kmono、K1和k2),并由此推导心肌氧耗量和心肌外部效率。

主要发现

  • 重度饮酒组心肌氧耗量为0.121±0.018 mL·g-1·min-1,酒精性心肌病组为0.111±0.017 mL·g-1·min-1,均显著低于健康对照组的0.144±0.023 mL·g-1·min-1和中度饮酒组的0.146±0.027 mL·g-1·min-1(P<.01)。
  • 酒精性心肌病组心肌外部效率为13.0%±4.3%,显著低于健康对照组的22.4%±4.6%(P<.01)、中度饮酒组的20.1%±4.5%(P<.05)和重度饮酒组的22.3%±4.5%(P<.001)。

关键数值与推荐

  • 重度饮酒组心肌氧耗量0.121±0.018 mL·g-1·min-1 vs 健康对照组0.144±0.023 mL·g-1·min-1(P<.01)。
  • 酒精性心肌病组心肌氧耗量0.111±0.017 mL·g-1·min-1 vs 健康对照组0.144±0.023 mL·g-1·min-1(P<.01)。
  • 酒精性心肌病组心肌外部效率13.0%±4.3% vs 健康对照组22.4%±4.6%(P<.01)。
  • 酒精性心肌病组心肌外部效率13.0%±4.3% vs 中度饮酒组20.1%±4.5%(P<.05)。
  • 酒精性心肌病组心肌外部效率13.0%±4.3% vs 重度饮酒组22.3%±4.5%(P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The purpose of this study was to evaluate subjects with high-risk alcohol cardiotoxicity and patients with alcoholic cardiomyopathy (ACM) via dynamic 11C-Acetate positron emission tomography (PET) imaging as a myocardial oxidative metabolic probe. METHODS AND RESULTS: We recruited 37 subjects with chronic alcohol consumption [18 with moderate consumption (MC), 19 with heavy consumption (HC)], 5 ACM patients, and 12 healthy controls to receive dynamic 11C-Acetate PET scans. PET imaging data were analyzed to calculate kinetic parameters (e.g., Kmono, K1 and k2) based on the mono-exponential and one-tissue compartmental models. Myocardial oxygen consumption (MVO2) and myocardial external efficiency (MEE) were then derived from these kinetic parameters. MVO2 was significantly lowered in the HC group and in ACM patients (0.121± 0.018 and 0.111 ± 0.017 mL·g-1·min-1, respectively) compared with those in healthy controls and MC subjects (0.144 ± 0.023 and 0.146 ± 0.027 mL·g-1·min-1, respectively; P < .01). MEE was significantly reduced in ACM patients (13.0% ± 4.3%) compared with those of healthy controls (22.4% ± 4.6%, P < .01), MC subjects (20.1% ± 4.5%, P < .05), and HC subjects (22.3% ± 4.5%, P < .001). CONCLUSION: Functional assessment via dynamic 11C-Acetate PET imaging may represent a clinically feasible probe for identifying cohorts with high-risk cardiotoxicity due to addictive alcohol consumption and ACM.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Shi X, Liu S, Lin X, et al. Characterization of myocardial oxidative metabolism and myocardial external efficiency in high-risk alcohol cardiotoxicity and alcoholic cardiomyopathy via dynamic 11C-Acetate positron emission tomography. J Nucl Cardiol. 2020. PMID: 32557237. doi:10.1007/s12350-020-02214-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。